| Prosthetic Specialists Of Washingto | |
| 11417 124th Ave Ne, Ste 103, Kirkland, Washington 98033 | |
| (425) 576-5050 |
| Name | Prosthetic Specialists Of Washingto |
|---|---|
| Organization Name | Prosthetic Specialists Of Washington |
| Location | 11417 124th Ave Ne, Ste 103, Kirkland, Washington 98033 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (425) 576-5050 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The U.S. Food and Drug Administration today announced that it has awarded 83 grants in FY2009 totaling $17.5 million to state and local regulatory agencies to boost food and feed safety initiatives among federal, state, and local partners.
Obesity is a complicating factor for many surgical patients. In a recent study published in the Journal of Heart and Lung Transplantation, Mayo Clinic researchers have shown that losing weight can have a positive impact on outcomes for lung transplant patients.
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. The study was conducted on a subset of patients enrolled in the NCIC Clinical Trials Group, BR.21 phase III trial of erlotinib versus placebo in previously treated advanced non-small cell lung cancer patients.
DNA Therapeutics, a private biopharmaceutical company developing DT01, a first-in-class clinical pan DNA repair inhibitor to treat tumors resistant to conventional treatments, will today present the results of the first-in-man phase 1/2a trial of DT01 in combination with radiation therapy in patients with cutaneous metastatic melanoma.
› Verified 4 days ago
| NPI Number | 1558641886 |
| Organization Name | PROSTHETIC SPECIALISTS OF WASHINGTON |
| Type | Prosthetic/Orthotic Supplier |
| Address | 11417 124th Ave Ne Ste 103, Kirkland, WA 98033 |
| Phone Number | 425-576-5050 |
News Archive
The U.S. Food and Drug Administration today announced that it has awarded 83 grants in FY2009 totaling $17.5 million to state and local regulatory agencies to boost food and feed safety initiatives among federal, state, and local partners.
Obesity is a complicating factor for many surgical patients. In a recent study published in the Journal of Heart and Lung Transplantation, Mayo Clinic researchers have shown that losing weight can have a positive impact on outcomes for lung transplant patients.
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. The study was conducted on a subset of patients enrolled in the NCIC Clinical Trials Group, BR.21 phase III trial of erlotinib versus placebo in previously treated advanced non-small cell lung cancer patients.
DNA Therapeutics, a private biopharmaceutical company developing DT01, a first-in-class clinical pan DNA repair inhibitor to treat tumors resistant to conventional treatments, will today present the results of the first-in-man phase 1/2a trial of DT01 in combination with radiation therapy in patients with cutaneous metastatic melanoma.
› Verified 4 days ago
News Archive
The U.S. Food and Drug Administration today announced that it has awarded 83 grants in FY2009 totaling $17.5 million to state and local regulatory agencies to boost food and feed safety initiatives among federal, state, and local partners.
Obesity is a complicating factor for many surgical patients. In a recent study published in the Journal of Heart and Lung Transplantation, Mayo Clinic researchers have shown that losing weight can have a positive impact on outcomes for lung transplant patients.
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. The study was conducted on a subset of patients enrolled in the NCIC Clinical Trials Group, BR.21 phase III trial of erlotinib versus placebo in previously treated advanced non-small cell lung cancer patients.
DNA Therapeutics, a private biopharmaceutical company developing DT01, a first-in-class clinical pan DNA repair inhibitor to treat tumors resistant to conventional treatments, will today present the results of the first-in-man phase 1/2a trial of DT01 in combination with radiation therapy in patients with cutaneous metastatic melanoma.
› Verified 4 days ago
Fred Meyer Pharmacy # 391 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12221 120th Ave, Kirkland, Washington 98034 Phone: (425) 820-3233 | |
Qfc Pharmacy #828 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11224ne124th St, Kirkland, Washington 98034 Phone: (425) 820-0440 | |
Qfc Pharmacy 894 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 425 Urban Plz, Kirkland, Washington 98033 Phone: (425) 822-4123 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 12039 Ne 128th St, Kirkland, Washington 98034 Phone: (425) 814-3258 | |
Northwest Eye Design Llc Type: Prosthetic/Orthotic Supplier Location: 12911 120th Ave Ne, Kirkland, Washington 98034 Phone: (425) 823-1861 |